期刊文献+

大黄酸及其酯化衍生物在大鼠体内的药代动力学研究(英文)

Pharmacokinetic Study of Rhein and its Carboxyl-esterification Derivatives in Rats
原文传递
导出
摘要 目的:研究大黄酸羧基酯化对其在大鼠体内药动行为的影响。方法:采用大黄酸甲酯和大黄酸乙酯作为模型药, 大黄酸作为阳性对照, 对大鼠单次灌胃70 mg·kg-1或者单次静注 0.7 mg·kg-1, HPLC 荧光同时监测大鼠血浆中三种分析物的血浓经时变化。结果:大黄酸甲酯和大黄酸乙酯灌胃和静注给予大鼠后, 血浆中均测不到酯类原型, 但能测到一定量的大黄酸。将甲酯和乙酯衍生物灌胃后在大鼠血浆中所测得的大黄酸成分的经时变化与直接灌胃大黄酸后大鼠血浆中大黄酸成分的经时过程相比较, 其主要的药动参数分别为:cmax (0.058 ± 0.035)、(0.95 ± 0.090)、(42.66 ± 14.41) mg·L-1; Tmax (6.7 ± 2.3)、(10.7 ± 2.3)、(0.9 ± 0.1) h; t1/2β (6.0 ± 1.7)、(6.4 ± 1.0)、(3.2 ± 0.6) h; AUC0-∞ (1.03 ± 0.76)、(12.79 ± 0.96)、(80.28 ± 13.59) h·mg·L-1。结论:羧基酯化降低了大黄酸在大鼠体内的有效暴露剂量, 提示此类衍生物不适于作为大黄酸的前体药物进行开发。 AIM: To explore the effects of carboxyl-esterification on pharmacokinetics of rhein in rat. METHODS: Rhein methylate (REM) and Rhein ethylate (REE) were used as model drugs while rhein (RE) as a positive control. The simultaneous detec- tion of three analytes in rat plasma samples was carried out by an HPLC-fluorescence method. Single dose of RE, REM or REE was administered to rats by both ig route at 70 mg.kg-1 and iv route at 0.7 mg.kg-1. RESULTS: REM and REE were entirely metabolized to rhein after ig and iv administration of either REE or REM to rats and only rhein was detected in plasma. Therefore, the pharmacoki- netic comparisons among RE, REE and REM in rat were carried out based on the profiles of rhein in rat plasma after the administration of each compound. The main pharmacokinetic parameters of REM, REE and RE after ig administration were as follows: Cmax (0.058 ± 0.035), (0.95 ± 0.090), (42.66± 14.41) mg.L-1; Tmax (6.7 ± 2.3), (10.7 ± 2.3), (0.9 ± 0.1) h; tl/2β(6.0 ± 1.7), (6.4 ± 1.0), (3.2 ± 0.6) h; AUCo-∞ (1.03 ± 0.76), (12.79± 0.96), (80.28 ±13.59) h.mg.L-1. CONCLUSION: It was found that the reconstruction of carboxyl - esterification has significantly reduced the net exposure amount of rhein in vivo, leading to its inaptitude in the development of drug precursors of rhein.
出处 《中国天然药物》 SCIE CAS CSCD 北大核心 2009年第3期228-233,共6页
基金 supported by the National‘863’Projects ( No. 2002AA2Z3 113 No. 2003AA2Z347A No. 2005AA2Z3C70 ) the Key Lab of Drug Metabolism and Phar-macokinetics of Jiangsu Province( No. BM2001201)~~
关键词 大黄酸 羧基酯化 大鼠体内药动学 HPLC Rhein Carboxyl-esterification Pharmacokinetics HPLC Rat
  • 相关文献

参考文献2

二级参考文献18

  • 1欧宁,顾进华,董群.大黄蒽醌衍生物的家兔药物动力学研究[J].中成药,1993,15(7):8-9. 被引量:3
  • 2王新宏,范广平,安睿,王智华.大鼠血浆中大黄蒽醌甙元的HPLC分析方法学研究[J].中成药,1997,19(1):37-39. 被引量:16
  • 3吴梧桐主编.生物化学:第4版[M].北京:人民卫生出版社,1998.220. 被引量:1
  • 4Xie J N, Chen L R, Li C X, et al. Selective extraction of functional components derived from herb in plasma by using a molecularly imprinted polymer based on 2,2-bis(hydroxymetayl) butanol trimethacrylate. J Chromatography B, 2003, 788 : 233. 被引量:1
  • 5XuXJ, Zhu L L, ChenL R. Separation and screening of compotads of biological origin using molecularly imprinted polymers. J Chromatography B, 2004, 804:61. 被引量:1
  • 6Li C, Honana Macro, Ohkura Naoki, et al. (S)-dihydroomxylin A in human urine fdlowing oral administration of the traditional Chinese medicines: Daisaiko-to and Shosaiko-to. Tetrahedrom Asyrrunetry,1997,8(8):1145. 被引量:1
  • 7Li C, Homma Macro, Oka Kitaro. Chromatographic identification of phenolic compounds in human urine following oral administration of the herbal medicines Daisaik o-to and Shesaiko-to. J Chromatography B, 1997, 693: 191. 被引量:1
  • 8Ding M Y, Ma S, Liu D. Simultanotms determination of hydroxyanthraquinones in rhubarb and experimental animal bodies by high-performance liquid chromatography. Arial Sic, 2003, 19(8):1165. 被引量:1
  • 9Yukiho Takizawa, Takashi Morota, Shuichi Takeda, et al. Phanna-cokinetlc of rhein from Onpi-to, an oriental herbal medicine, in rats.Biol Pharm Bull, 2003, 26(5):613. 被引量:1
  • 10Je-Hyum Lee, Jong Moon Kim, Chungsook Kim. Phammcolinetic analysis of rhein in Rheum undulatum L. . J Ednopharmacol , 2002,84:5. 被引量:1

共引文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部